vTv Therapeutics Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.009 million compared to USD 0.009 million a year ago. Net loss was USD 3.15 million compared to USD 0.608 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.01 a year ago.
For the six months, sales was USD 2.01 million compared to USD 0.996 million a year ago. Net loss was USD 10.16 million compared to USD 4.85 million a year ago. Basic loss per share from continuing operations was USD 0.15 compared to USD 0.08 a year ago.